small-molecule and a multitarget tki anlotinib (MultiTarget Pharmaceuticals)
90
Structured Review
MultiTarget Pharmaceuticals
small-molecule and a multitarget tki anlotinib
Small Molecule And A Multitarget Tki Anlotinib, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitarget+small+molecule/anlotinib/pmc12198539-51-6-4
Average 90 stars, based on 1 article reviews
Small Molecule And A Multitarget Tki Anlotinib, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitarget+small+molecule/anlotinib/pmc12198539-51-6-4
Average 90 stars, based on 1 article reviews
small-molecule and a multitarget tki anlotinib - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis"
Article Title: Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis
Journal: Therapeutic Advances in Medical Oncology
doi: 10.1177/17588359251348310
Figure Legend Snippet: Network diagrams of comparisons on different treatments. Direct comparisons are represented by the colored lines connecting the treatments. Line width is proportional to the number of trials, including every pair of treatments, whereas circle size is proportional to the total number of patients for each treatment in the network. Adeb, Adebrelimab; Atez, Atezolizumab; Atez-beva, Atezolizumab + bevacizumab; Benm + anlo, Benmelstobart + anlotinib; Durv, Durvalumab; Nivo, Nivolumab; Pemb, Pembrolizumab; Pla, placebo; Serp, Serplulimab; Tira + atez, Tiragolumabz + atezolizumab; Tisl, Tislelizumab; Tori, Toripalimab.
Techniques Used:
Figure Legend Snippet: HRs, ORs, and their 95% confidence intervals from network meta-analysis of different first-line therapeutic regimens in ES-SCLC patients. (a) HRs and 95% CI for overall survival (upper triangle in yellow) and progression-free survival (lower triangle in green). The hazard ratio < 1.00 provides better survival benefits. (b) ORs and 95% CI for objective response rate (upper triangle in yellow) and grade ⩾ 3 adverse events (lower triangle in green). OR < 1.00 indicates a better efficacy or more toxicity. The results are presented as column-defined treatment versus row-defined treatment. Significant results are in bold. Adeb, Adebrelimab; Atez, Atezolizumab; Atez-beva, Atezolizumab + bevacizumab; Benm-anlo, Benmelstobart + anlotinib; Chemo, Chemotherapy; CI, confidence intervals; Durv, Durvalumab; ES-SCLC, extensive-stage small-cell lung cancer; HR, hazard ratios; Nivo, Nivolumab; OR, odds ratio; Pemb, Pembrolizumab; Serp, Serplulimab; Tisl, Tislelizumab; Tori, Toripalimab.
Techniques Used:
Figure Legend Snippet: Bayesian ranking profiles of comparable treatments on efficacy and safety for ES-SCLC patients. Ranking plots indicate the probability of each comparable immunotherapy combination being ranked from first to last on OS, PFS, ORR, and grade ⩾ 3 AEs. Adeb, Adebrelimab; AE, adverse event; Atez, Atezolizumab; Atez-beva, Atezolizumab + bevacizumab; Benm-anlo, Benmelstobart + anlotinib; Durv, Durvalumab; ES-SCLC, extensive-stage small-cell lung cancer; Nivo, Nivolumab; ORR, overall response rate; OS, overall survival; Pemb, Pembrolizumab; PFS, progression-free survival; Serp, Serplulimab; Tisl, Tislelizumab; Tori, Toripalimab.
Techniques Used:
Related Articles
Concentration Assay:Article Title: α-Phenyl- N-tert -Butylnitrone and Analogous α-Aryl- N -alkylnitrones as Neuroprotective Antioxidant Agents for Stroke. Article Snippet: .. Abbreviations Adenosine diphosphate (ADP); Area under the concentration (AUC); Brain-derived neurotrophic factor (BDNF); tert-Butylhydroperoxide (t-BHP); 3-n-Butylphthalide (NBP); Cerebellum granular neurons (CGNs); Cerebral ischemia (CI); 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT); 2,2-Diphenyl-1-picrylhydrazyl (DPPH); Edaravone (Eda); Glutathione (GSH); Hydrogen peroxide (H2O2); 6-Hydroxydopamine (6-OHDA); Hydroxyl radical (.OH); Intraperitoneal (ip); Intravenous (iv); Malondialdehyde (MDA); Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); 1-Methyl-4-phenylpyridinium (MPP+); Middle cerebral artery occlusion (MCAO); MTT Assay:Article Title: α-Phenyl- N-tert -Butylnitrone and Analogous α-Aryl- N -alkylnitrones as Neuroprotective Antioxidant Agents for Stroke. Article Snippet: .. Abbreviations Adenosine diphosphate (ADP); Area under the concentration (AUC); Brain-derived neurotrophic factor (BDNF); tert-Butylhydroperoxide (t-BHP); 3-n-Butylphthalide (NBP); Cerebellum granular neurons (CGNs); Cerebral ischemia (CI); 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT); 2,2-Diphenyl-1-picrylhydrazyl (DPPH); Edaravone (Eda); Glutathione (GSH); Hydrogen peroxide (H2O2); 6-Hydroxydopamine (6-OHDA); Hydroxyl radical (.OH); Intraperitoneal (ip); Intravenous (iv); Malondialdehyde (MDA); Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); 1-Methyl-4-phenylpyridinium (MPP+); Middle cerebral artery occlusion (MCAO); Multiple Displacement Amplification:Article Title: α-Phenyl- N-tert -Butylnitrone and Analogous α-Aryl- N -alkylnitrones as Neuroprotective Antioxidant Agents for Stroke. Article Snippet: .. Abbreviations Adenosine diphosphate (ADP); Area under the concentration (AUC); Brain-derived neurotrophic factor (BDNF); tert-Butylhydroperoxide (t-BHP); 3-n-Butylphthalide (NBP); Cerebellum granular neurons (CGNs); Cerebral ischemia (CI); 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT); 2,2-Diphenyl-1-picrylhydrazyl (DPPH); Edaravone (Eda); Glutathione (GSH); Hydrogen peroxide (H2O2); 6-Hydroxydopamine (6-OHDA); Hydroxyl radical (.OH); Intraperitoneal (ip); Intravenous (iv); Malondialdehyde (MDA); Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); 1-Methyl-4-phenylpyridinium (MPP+); Middle cerebral artery occlusion (MCAO); Recombinant:Article Title: α-Phenyl- N-tert -Butylnitrone and Analogous α-Aryl- N -alkylnitrones as Neuroprotective Antioxidant Agents for Stroke. Article Snippet: .. Abbreviations Adenosine diphosphate (ADP); Area under the concentration (AUC); Brain-derived neurotrophic factor (BDNF); tert-Butylhydroperoxide (t-BHP); 3-n-Butylphthalide (NBP); Cerebellum granular neurons (CGNs); Cerebral ischemia (CI); 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT); 2,2-Diphenyl-1-picrylhydrazyl (DPPH); Edaravone (Eda); Glutathione (GSH); Hydrogen peroxide (H2O2); 6-Hydroxydopamine (6-OHDA); Hydroxyl radical (.OH); Intraperitoneal (ip); Intravenous (iv); Malondialdehyde (MDA); Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); 1-Methyl-4-phenylpyridinium (MPP+); Middle cerebral artery occlusion (MCAO); other:Article Title: Piperidine Nucleus as a Promising Scaffold for Alzheimer's Disease: Current Landscape and Future Perspective. Article Snippet: Heterocycles and their derivatives hold an important place in medicinal chemistry due to their vast therapeutic and pharmacological significance and wider implications in drug design and development.. Piperidine is a nitrogen-containing heterocyclic moiety that exhibits an array of pharmacological properties.. This review discusses the potential of piperidine derivatives against the neurodegenerative disease Alzheimer’s. |
